Section

Dr Reddy's enters licensing pact to market Pharmazz novel therapy Centhaquine in India

By Economic Times - 4 months ago
Dr. Reddy’s collaborates with Pharmazz to introduce Centhaquine as Lyfaquin in India, aiming to improve hypovolemic shock treatment. The partnership includes marketing rights for Nepal and addresses the high mortality rate in traumatic haemorrhages.

Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.